The Key to Emotional Balance
ConditionThe Key to Emotional Balance
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTC Erciyes University
About this trial
This randomized controlled experimental study aimed to evaluate the effects of the Key to Emotional Balance (KBA) psychoeducational program, based on the Balance Model of Positive Psychotherapy (PPT), on indicators of emotion regulation difficulties, recovery, and purpose in life in adults with bipolar disorder. Intervention and control groups (n=37 each; total n=74) will be formed through simple random assignment. The intervention will consist of eight individual sessions, each lasting 40-50 minutes. Data will be collected using the Difficulty in Emotion Regulation, Recovery Assessment Scale, and the Life Goals Scale in the Context of PPT. Measurements will be conducted as a pretest and posttest.
Eligibility criteria
Qualifiers
Having a diagnosis of bipolar I or bipolar II disorder according to the DSM-5.
Being between 18 and 65 years of age.
Being literate and having the cognitive capacity to participate in written questionnaires.
Being in a stable mood/remission (neither severely manic nor severely depressed) at the start of the study.
Disqualifiers
Being in an episode of acute mania or severe depression.
Having a diagnosis of another serious psychiatric disorder such as schizophrenia, schizoaffective disorder, severe anxiety disorder, or obsessive-compulsive disorder (OCD).
Cognitive impairments, such as dementia, severe cognitive impairment, or mental retardation, that would prevent participation in the recommended therapy.
Individuals with a history of substance abuse within the last 6 months or ongoing active substance use.
Trial design
Treatments tested in this trial
- The Key to Emotional Balance
Treatment groups
74 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
TC Erciyes University
Lead sponsor
The Scientific and Technological Research Council of Turkey
Collaborator
Source ClinicalTrials.gov